Clinical Trial Update: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases [Phase 1]

View source ↗

Summary

Update on a Phase 1 clinical trial evaluating intraventricular administration of Rhenium-186 NanoLiposome for leptomeningeal metastasis, sponsored by Plus Thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• Rhenium-186 NanoLiposome (Rhenium-186 NanoLiposome)

Snippet

Sponsor: Plus Therapeutics | Conditions: Leptomeningeal Metastasis | Phase 1 | Status: ACTIVE_NOT_RECRUITING